Structure

Physi-Chem Properties

Molecular Weight:  330.18
Volume:  350.785
LogP:  2.927
LogD:  1.356
LogS:  -3.334
# Rotatable Bonds:  1
TPSA:  74.6
# H-Bond Aceptor:  4
# H-Bond Donor:  2
# Rings:  3
# Heavy Atoms:  4

MedChem Properties

QED Drug-Likeness Score:  0.827
Synthetic Accessibility Score:  4.272
Fsp3:  0.6
Lipinski Rule-of-5:  Accepted
Pfizer Rule:  Accepted
GSK Rule:  Accepted
BMS Rule:  0
Golden Triangle Rule:  Accepted
Chelating Alert:  0
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -4.705
MDCK Permeability:  1.8282851669937372e-05
Pgp-inhibitor:  0.284
Pgp-substrate:  0.958
Human Intestinal Absorption (HIA):  0.011
20% Bioavailability (F20%):  0.707
30% Bioavailability (F30%):  0.03

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.51
Plasma Protein Binding (PPB):  85.2041244506836%
Volume Distribution (VD):  1.911
Pgp-substrate:  21.042116165161133%

ADMET: Metabolism

CYP1A2-inhibitor:  0.028
CYP1A2-substrate:  0.704
CYP2C19-inhibitor:  0.094
CYP2C19-substrate:  0.892
CYP2C9-inhibitor:  0.303
CYP2C9-substrate:  0.942
CYP2D6-inhibitor:  0.032
CYP2D6-substrate:  0.277
CYP3A4-inhibitor:  0.101
CYP3A4-substrate:  0.741

ADMET: Excretion

Clearance (CL):  7.883
Half-life (T1/2):  0.307

ADMET: Toxicity

hERG Blockers:  0.007
Human Hepatotoxicity (H-HT):  0.244
Drug-inuced Liver Injury (DILI):  0.66
AMES Toxicity:  0.035
Rat Oral Acute Toxicity:  0.374
Maximum Recommended Daily Dose:  0.904
Skin Sensitization:  0.305
Carcinogencity:  0.024
Eye Corrosion:  0.006
Eye Irritation:  0.826
Respiratory Toxicity:  0.954

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC475957

Natural Product ID:  NPC475957
Common Name*:   Hypargenin A
IUPAC Name:   (4aS,10S,10aS)-6,10-dihydroxy-1,1,4a-trimethyl-7-propan-2-yl-2,3,10,10a-tetrahydrophenanthrene-4,9-dione
Synonyms:  
Standard InCHIKey:  MJQYLJQAKPFSAI-HBFSDRIKSA-N
Standard InCHI:  InChI=1S/C20H26O4/c1-10(2)11-8-12-13(9-14(11)21)20(5)15(22)6-7-19(3,4)18(20)17(24)16(12)23/h8-10,17-18,21,24H,6-7H2,1-5H3/t17-,18+,20+/m1/s1
SMILES:  CC(C)C1=C(C=C2C(=C1)C(=O)C(C3C2(C(=O)CCC3(C)C)C)O)O
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL519712
PubChem CID:   14239563
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000012] Lipids and lipid-like molecules
      • [CHEMONTID:0000259] Prenol lipids
        • [CHEMONTID:0001551] Diterpenoids

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO26904 Salvia hypargeia Species Lamiaceae Eukaryota roots n.a. n.a. PMID[3236010]
NPO26904 Salvia hypargeia Species Lamiaceae Eukaryota n.a. n.a. n.a. Database[UNPD]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT16 Organism Staphylococcus aureus Staphylococcus aureus MIC = 15.6 ug.mL-1 PMID[450040]
NPT173 Organism Klebsiella pneumoniae Klebsiella pneumoniae MIC = 15.6 ug.mL-1 PMID[450040]
NPT16 Organism Staphylococcus aureus Staphylococcus aureus IZ > 7.0 mm PMID[450040]
NPT17 Organism Staphylococcus epidermidis Staphylococcus epidermidis IZ > 7.0 mm PMID[450040]
NPT18 Organism Pseudomonas aeruginosa Pseudomonas aeruginosa IZ > 7.0 mm PMID[450040]
NPT79 Organism Bacillus subtilis Bacillus subtilis IZ > 7.0 mm PMID[450040]
NPT173 Organism Klebsiella pneumoniae Klebsiella pneumoniae IZ > 7.0 mm PMID[450040]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC475957 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
0.9692 High Similarity NPC78307
0.947 High Similarity NPC202225
0.9394 High Similarity NPC477139
0.9389 High Similarity NPC471851
0.9237 High Similarity NPC171460
0.9231 High Similarity NPC78364
0.9231 High Similarity NPC176130
0.9231 High Similarity NPC69424
0.9231 High Similarity NPC84672
0.9203 High Similarity NPC248068
0.9167 High Similarity NPC108129
0.9149 High Similarity NPC5568
0.9084 High Similarity NPC72667
0.9015 High Similarity NPC3009
0.9008 High Similarity NPC254492
0.9 High Similarity NPC181334
0.8947 High Similarity NPC276238
0.8947 High Similarity NPC303910
0.8944 High Similarity NPC143685
0.8921 High Similarity NPC471853
0.8873 High Similarity NPC478160
0.8855 High Similarity NPC199273
0.8824 High Similarity NPC111845
0.8815 High Similarity NPC93015
0.8803 High Similarity NPC79627
0.8794 High Similarity NPC308572
0.8788 High Similarity NPC123506
0.8788 High Similarity NPC137750
0.8779 High Similarity NPC471187
0.8777 High Similarity NPC230811
0.8768 High Similarity NPC474311
0.8732 High Similarity NPC478164
0.8731 High Similarity NPC96024
0.8702 High Similarity NPC282577
0.8686 High Similarity NPC138472
0.8686 High Similarity NPC52407
0.8676 High Similarity NPC476847
0.8671 High Similarity NPC471906
0.8662 High Similarity NPC135524
0.8647 High Similarity NPC87985
0.8633 High Similarity NPC86524
0.8633 High Similarity NPC471670
0.8633 High Similarity NPC472308
0.863 High Similarity NPC474310
0.8626 High Similarity NPC154696
0.8601 High Similarity NPC100242
0.8592 High Similarity NPC305845
0.8592 High Similarity NPC204045
0.8582 High Similarity NPC15837
0.8582 High Similarity NPC71610
0.8561 High Similarity NPC153088
0.8561 High Similarity NPC11250
0.8561 High Similarity NPC80035
0.8552 High Similarity NPC314437
0.8551 High Similarity NPC314048
0.8551 High Similarity NPC115458
0.8531 High Similarity NPC469855
0.8531 High Similarity NPC477209
0.8531 High Similarity NPC193555
0.8531 High Similarity NPC471972
0.8531 High Similarity NPC471971
0.8531 High Similarity NPC30846
0.8531 High Similarity NPC474961
0.8521 High Similarity NPC476534
0.8519 High Similarity NPC262936
0.8519 High Similarity NPC30491
0.8511 High Similarity NPC13715
0.8511 High Similarity NPC4214
0.8496 Intermediate Similarity NPC198014
0.8496 Intermediate Similarity NPC273683
0.8493 Intermediate Similarity NPC52692
0.8489 Intermediate Similarity NPC23894
0.8489 Intermediate Similarity NPC474659
0.8467 Intermediate Similarity NPC199253
0.8467 Intermediate Similarity NPC136588
0.8456 Intermediate Similarity NPC48248
0.844 Intermediate Similarity NPC277559
0.844 Intermediate Similarity NPC477592
0.844 Intermediate Similarity NPC49911
0.844 Intermediate Similarity NPC36868
0.8433 Intermediate Similarity NPC68756
0.8433 Intermediate Similarity NPC152525
0.8421 Intermediate Similarity NPC91478
0.8421 Intermediate Similarity NPC176208
0.8417 Intermediate Similarity NPC4170
0.8417 Intermediate Similarity NPC53896
0.8417 Intermediate Similarity NPC59459
0.8414 Intermediate Similarity NPC469856
0.8414 Intermediate Similarity NPC244691
0.8414 Intermediate Similarity NPC469854
0.8409 Intermediate Similarity NPC32322
0.8409 Intermediate Similarity NPC259703
0.8406 Intermediate Similarity NPC291001
0.8406 Intermediate Similarity NPC164295
0.8406 Intermediate Similarity NPC17083
0.8394 Intermediate Similarity NPC25736
0.8392 Intermediate Similarity NPC315578
0.8392 Intermediate Similarity NPC181560
0.8392 Intermediate Similarity NPC169452
0.838 Intermediate Similarity NPC469680
0.838 Intermediate Similarity NPC471974
0.838 Intermediate Similarity NPC469681
0.8369 Intermediate Similarity NPC272268
0.8369 Intermediate Similarity NPC315275
0.8367 Intermediate Similarity NPC478018
0.8358 Intermediate Similarity NPC275145
0.8357 Intermediate Similarity NPC50924
0.8356 Intermediate Similarity NPC34482
0.8346 Intermediate Similarity NPC120545
0.8346 Intermediate Similarity NPC162935
0.8346 Intermediate Similarity NPC253627
0.8346 Intermediate Similarity NPC249340
0.8345 Intermediate Similarity NPC165612
0.8345 Intermediate Similarity NPC66593
0.8345 Intermediate Similarity NPC70622
0.8333 Intermediate Similarity NPC272907
0.8333 Intermediate Similarity NPC2681
0.8333 Intermediate Similarity NPC27659
0.8333 Intermediate Similarity NPC31799
0.8333 Intermediate Similarity NPC253488
0.8322 Intermediate Similarity NPC242994
0.8322 Intermediate Similarity NPC26924
0.8322 Intermediate Similarity NPC190457
0.8322 Intermediate Similarity NPC162939
0.8322 Intermediate Similarity NPC138099
0.8321 Intermediate Similarity NPC229894
0.831 Intermediate Similarity NPC53001
0.831 Intermediate Similarity NPC471452
0.831 Intermediate Similarity NPC119542
0.831 Intermediate Similarity NPC471905
0.8308 Intermediate Similarity NPC477137
0.8308 Intermediate Similarity NPC308311
0.8308 Intermediate Similarity NPC38893
0.8299 Intermediate Similarity NPC470570
0.8299 Intermediate Similarity NPC136878
0.8299 Intermediate Similarity NPC471970
0.8298 Intermediate Similarity NPC477596
0.8298 Intermediate Similarity NPC22644
0.8298 Intermediate Similarity NPC103082
0.8298 Intermediate Similarity NPC283088
0.8296 Intermediate Similarity NPC74507
0.8296 Intermediate Similarity NPC234890
0.8288 Intermediate Similarity NPC196941
0.8288 Intermediate Similarity NPC29932
0.8288 Intermediate Similarity NPC309169
0.8288 Intermediate Similarity NPC48762
0.8286 Intermediate Similarity NPC225051
0.8286 Intermediate Similarity NPC49742
0.8278 Intermediate Similarity NPC472211
0.8276 Intermediate Similarity NPC85310
0.8276 Intermediate Similarity NPC201297
0.8276 Intermediate Similarity NPC184935
0.8276 Intermediate Similarity NPC469520
0.8276 Intermediate Similarity NPC73061
0.8273 Intermediate Similarity NPC41847
0.8273 Intermediate Similarity NPC239134
0.8273 Intermediate Similarity NPC18798
0.8271 Intermediate Similarity NPC472981
0.8261 Intermediate Similarity NPC117899
0.8261 Intermediate Similarity NPC99731
0.8258 Intermediate Similarity NPC473767
0.8258 Intermediate Similarity NPC476645
0.8252 Intermediate Similarity NPC87723
0.8252 Intermediate Similarity NPC91887
0.8252 Intermediate Similarity NPC50615
0.8252 Intermediate Similarity NPC51531
0.8252 Intermediate Similarity NPC477849
0.8252 Intermediate Similarity NPC114333
0.8252 Intermediate Similarity NPC5014
0.8252 Intermediate Similarity NPC165191
0.8252 Intermediate Similarity NPC157284
0.8252 Intermediate Similarity NPC46242
0.8252 Intermediate Similarity NPC297797
0.8252 Intermediate Similarity NPC289358
0.8252 Intermediate Similarity NPC42384
0.8252 Intermediate Similarity NPC473479
0.8252 Intermediate Similarity NPC28592
0.8252 Intermediate Similarity NPC23667
0.8252 Intermediate Similarity NPC245760
0.8252 Intermediate Similarity NPC473779
0.8252 Intermediate Similarity NPC149773
0.8252 Intermediate Similarity NPC477593
0.8252 Intermediate Similarity NPC469857
0.8243 Intermediate Similarity NPC478163
0.8239 Intermediate Similarity NPC191976
0.8239 Intermediate Similarity NPC38158
0.8239 Intermediate Similarity NPC254847
0.8239 Intermediate Similarity NPC193358
0.8231 Intermediate Similarity NPC192948
0.8231 Intermediate Similarity NPC478019
0.8231 Intermediate Similarity NPC12402
0.8231 Intermediate Similarity NPC35797
0.8227 Intermediate Similarity NPC12070
0.8227 Intermediate Similarity NPC477594
0.8201 Intermediate Similarity NPC198305
0.8194 Intermediate Similarity NPC294330
0.8188 Intermediate Similarity NPC473719
0.8188 Intermediate Similarity NPC282923
0.8188 Intermediate Similarity NPC193203
0.8182 Intermediate Similarity NPC53414

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC475957 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.8239 Intermediate Similarity NPD1509 Clinical (unspecified phase)
0.806 Intermediate Similarity NPD3019 Approved
0.7985 Intermediate Similarity NPD4196 Clinical (unspecified phase)
0.7971 Intermediate Similarity NPD1470 Approved
0.7926 Intermediate Similarity NPD2932 Approved
0.7862 Intermediate Similarity NPD3299 Clinical (unspecified phase)
0.781 Intermediate Similarity NPD1201 Approved
0.78 Intermediate Similarity NPD7390 Discontinued
0.7748 Intermediate Similarity NPD7422 Clinical (unspecified phase)
0.7718 Intermediate Similarity NPD7003 Approved
0.7687 Intermediate Similarity NPD5408 Approved
0.7687 Intermediate Similarity NPD5406 Approved
0.7687 Intermediate Similarity NPD5404 Approved
0.7687 Intermediate Similarity NPD5405 Approved
0.7662 Intermediate Similarity NPD7458 Discontinued
0.7647 Intermediate Similarity NPD3091 Approved
0.7639 Intermediate Similarity NPD6663 Approved
0.7609 Intermediate Similarity NPD3023 Approved
0.7609 Intermediate Similarity NPD3026 Approved
0.7606 Intermediate Similarity NPD5736 Approved
0.7591 Intermediate Similarity NPD3024 Approved
0.7591 Intermediate Similarity NPD3025 Approved
0.7533 Intermediate Similarity NPD7421 Clinical (unspecified phase)
0.75 Intermediate Similarity NPD405 Clinical (unspecified phase)
0.7483 Intermediate Similarity NPD8166 Discontinued
0.7481 Intermediate Similarity NPD5951 Approved
0.7468 Intermediate Similarity NPD6273 Approved
0.7436 Intermediate Similarity NPD3226 Approved
0.7436 Intermediate Similarity NPD5808 Clinical (unspecified phase)
0.7429 Intermediate Similarity NPD3092 Approved
0.741 Intermediate Similarity NPD3095 Discontinued
0.7386 Intermediate Similarity NPD3300 Phase 2
0.7376 Intermediate Similarity NPD3972 Approved
0.7368 Intermediate Similarity NPD4628 Phase 3
0.7343 Intermediate Similarity NPD3094 Phase 2
0.7312 Intermediate Similarity NPD8443 Clinical (unspecified phase)
0.7301 Intermediate Similarity NPD6959 Discontinued
0.7286 Intermediate Similarity NPD3412 Clinical (unspecified phase)
0.7285 Intermediate Similarity NPD2346 Discontinued
0.7273 Intermediate Similarity NPD7236 Approved
0.7267 Intermediate Similarity NPD651 Clinical (unspecified phase)
0.723 Intermediate Similarity NPD943 Approved
0.7229 Intermediate Similarity NPD7473 Discontinued
0.7219 Intermediate Similarity NPD2935 Discontinued
0.7211 Intermediate Similarity NPD3764 Approved
0.7209 Intermediate Similarity NPD8150 Discontinued
0.7208 Intermediate Similarity NPD7910 Clinical (unspecified phase)
0.7185 Intermediate Similarity NPD4141 Clinical (unspecified phase)
0.7179 Intermediate Similarity NPD2534 Approved
0.7179 Intermediate Similarity NPD2533 Approved
0.7179 Intermediate Similarity NPD4378 Clinical (unspecified phase)
0.7179 Intermediate Similarity NPD2532 Approved
0.7163 Intermediate Similarity NPD7163 Clinical (unspecified phase)
0.7153 Intermediate Similarity NPD1283 Approved
0.7152 Intermediate Similarity NPD2799 Discontinued
0.7152 Intermediate Similarity NPD6232 Discontinued
0.7152 Intermediate Similarity NPD7239 Suspended
0.7143 Intermediate Similarity NPD7008 Discontinued
0.7143 Intermediate Similarity NPD7819 Suspended
0.7143 Intermediate Similarity NPD5844 Phase 1
0.7143 Intermediate Similarity NPD5952 Clinical (unspecified phase)
0.7121 Intermediate Similarity NPD1237 Approved
0.7105 Intermediate Similarity NPD6100 Approved
0.7105 Intermediate Similarity NPD6099 Approved
0.7103 Intermediate Similarity NPD1164 Approved
0.7092 Intermediate Similarity NPD1651 Approved
0.709 Intermediate Similarity NPD2342 Discontinued
0.708 Intermediate Similarity NPD7635 Approved
0.707 Intermediate Similarity NPD7004 Clinical (unspecified phase)
0.7063 Intermediate Similarity NPD4380 Phase 2
0.7059 Intermediate Similarity NPD1471 Phase 3
0.7045 Intermediate Similarity NPD7879 Clinical (unspecified phase)
0.7042 Intermediate Similarity NPD4626 Approved
0.7042 Intermediate Similarity NPD4059 Approved
0.7039 Intermediate Similarity NPD1510 Phase 2
0.7037 Intermediate Similarity NPD2393 Clinical (unspecified phase)
0.702 Intermediate Similarity NPD1607 Approved
0.7019 Intermediate Similarity NPD7411 Suspended
0.7013 Intermediate Similarity NPD970 Clinical (unspecified phase)
0.7012 Intermediate Similarity NPD7075 Discontinued
0.7 Intermediate Similarity NPD4060 Phase 1
0.7 Intermediate Similarity NPD4956 Approved
0.6987 Remote Similarity NPD6190 Approved
0.6978 Remote Similarity NPD2629 Approved
0.6957 Remote Similarity NPD6599 Discontinued
0.6948 Remote Similarity NPD2344 Approved
0.6944 Remote Similarity NPD1281 Approved
0.6939 Remote Similarity NPD2798 Approved
0.6933 Remote Similarity NPD7096 Clinical (unspecified phase)
0.6923 Remote Similarity NPD6398 Clinical (unspecified phase)
0.6919 Remote Similarity NPD5039 Approved
0.6918 Remote Similarity NPD1876 Approved
0.6912 Remote Similarity NPD6831 Clinical (unspecified phase)
0.6903 Remote Similarity NPD1549 Phase 2
0.6901 Remote Similarity NPD9545 Approved
0.6897 Remote Similarity NPD4878 Approved
0.6892 Remote Similarity NPD4208 Discontinued
0.6887 Remote Similarity NPD2979 Phase 3
0.6887 Remote Similarity NPD4140 Approved
0.6887 Remote Similarity NPD1240 Approved
0.6887 Remote Similarity NPD3620 Phase 2
0.6887 Remote Similarity NPD3619 Clinical (unspecified phase)
0.6879 Remote Similarity NPD5034 Approved
0.6879 Remote Similarity NPD4954 Approved
0.6879 Remote Similarity NPD36 Approved
0.6879 Remote Similarity NPD5026 Approved
0.6879 Remote Similarity NPD5028 Approved
0.6879 Remote Similarity NPD4955 Approved
0.6872 Remote Similarity NPD6535 Approved
0.6872 Remote Similarity NPD6534 Approved
0.6871 Remote Similarity NPD6801 Discontinued
0.6867 Remote Similarity NPD3268 Approved
0.6864 Remote Similarity NPD7852 Clinical (unspecified phase)
0.6864 Remote Similarity NPD6167 Clinical (unspecified phase)
0.6864 Remote Similarity NPD6166 Phase 2
0.6864 Remote Similarity NPD6168 Clinical (unspecified phase)
0.6855 Remote Similarity NPD7410 Clinical (unspecified phase)
0.6853 Remote Similarity NPD5691 Approved
0.6849 Remote Similarity NPD3600 Clinical (unspecified phase)
0.6849 Remote Similarity NPD1755 Approved
0.6848 Remote Similarity NPD4868 Clinical (unspecified phase)
0.6848 Remote Similarity NPD3882 Suspended
0.6846 Remote Similarity NPD1809 Phase 2
0.6839 Remote Similarity NPD1552 Clinical (unspecified phase)
0.6839 Remote Similarity NPD8312 Approved
0.6839 Remote Similarity NPD8313 Approved
0.6839 Remote Similarity NPD5035 Approved
0.6839 Remote Similarity NPD1550 Clinical (unspecified phase)
0.6838 Remote Similarity NPD9265 Clinical (unspecified phase)
0.6836 Remote Similarity NPD8397 Clinical (unspecified phase)
0.6831 Remote Similarity NPD7610 Discontinued
0.6821 Remote Similarity NPD8032 Phase 2
0.6821 Remote Similarity NPD5030 Phase 2
0.6821 Remote Similarity NPD7961 Discontinued
0.6818 Remote Similarity NPD8434 Phase 2
0.6818 Remote Similarity NPD3020 Approved
0.6815 Remote Similarity NPD3750 Approved
0.6797 Remote Similarity NPD4097 Suspended
0.6797 Remote Similarity NPD6651 Approved
0.6794 Remote Similarity NPD288 Approved
0.6788 Remote Similarity NPD8438 Clinical (unspecified phase)
0.6786 Remote Similarity NPD7159 Clinical (unspecified phase)
0.6784 Remote Similarity NPD7177 Discontinued
0.6779 Remote Similarity NPD9494 Approved
0.6776 Remote Similarity NPD6782 Approved
0.6776 Remote Similarity NPD6777 Approved
0.6776 Remote Similarity NPD6776 Approved
0.6776 Remote Similarity NPD6779 Approved
0.6776 Remote Similarity NPD6778 Approved
0.6776 Remote Similarity NPD6781 Approved
0.6776 Remote Similarity NPD6780 Approved
0.6774 Remote Similarity NPD2438 Suspended
0.6774 Remote Similarity NPD2796 Approved
0.6772 Remote Similarity NPD2309 Approved
0.6768 Remote Similarity NPD37 Approved
0.6768 Remote Similarity NPD1934 Approved
0.6763 Remote Similarity NPD6124 Clinical (unspecified phase)
0.6763 Remote Similarity NPD7993 Clinical (unspecified phase)
0.6761 Remote Similarity NPD8055 Clinical (unspecified phase)
0.6758 Remote Similarity NPD7700 Phase 2
0.6758 Remote Similarity NPD7699 Phase 2
0.6755 Remote Similarity NPD2313 Discontinued
0.6755 Remote Similarity NPD6798 Discontinued
0.6752 Remote Similarity NPD2800 Approved
0.6747 Remote Similarity NPD7058 Phase 2
0.6747 Remote Similarity NPD7057 Phase 3
0.6743 Remote Similarity NPD3534 Clinical (unspecified phase)
0.6739 Remote Similarity NPD3021 Approved
0.6739 Remote Similarity NPD3022 Approved
0.6739 Remote Similarity NPD4750 Phase 3
0.6732 Remote Similarity NPD6355 Discontinued
0.6732 Remote Similarity NPD230 Phase 1
0.6731 Remote Similarity NPD2343 Clinical (unspecified phase)
0.6727 Remote Similarity NPD5760 Phase 2
0.6727 Remote Similarity NPD5761 Phase 2
0.6726 Remote Similarity NPD5494 Approved
0.6725 Remote Similarity NPD5033 Approved
0.6723 Remote Similarity NPD5038 Approved
0.6723 Remote Similarity NPD5037 Approved
0.672 Remote Similarity NPD8320 Phase 1
0.672 Remote Similarity NPD8319 Approved
0.6718 Remote Similarity NPD844 Approved
0.671 Remote Similarity NPD7743 Approved
0.671 Remote Similarity NPD7742 Approved
0.669 Remote Similarity NPD2286 Discontinued
0.669 Remote Similarity NPD3317 Approved
0.6686 Remote Similarity NPD8127 Discontinued
0.6667 Remote Similarity NPD1930 Approved
0.6667 Remote Similarity NPD7696 Phase 3
0.6667 Remote Similarity NPD7697 Approved
0.6667 Remote Similarity NPD7435 Discontinued
0.6667 Remote Similarity NPD1931 Clinical (unspecified phase)
0.6667 Remote Similarity NPD1929 Approved
0.6667 Remote Similarity NPD7698 Approved
0.6667 Remote Similarity NPD9269 Phase 2
0.6667 Remote Similarity NPD3495 Discontinued
0.6667 Remote Similarity NPD4869 Clinical (unspecified phase)
0.6667 Remote Similarity NPD5036 Approved
0.6667 Remote Similarity NPD2531 Phase 2
0.6647 Remote Similarity NPD5711 Approved

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data